VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) ("the Company"), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, today announced that the Company has been invited to present a poster presentation at the sixth biennial Canadian Cancer Research Conference (CCRC), which is being held virtually November 8-11, 2021.
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.